Discontinuation report AVANDIA

Last updated on 2020-12-11 History
Report ID 113314
Drug Identification Number 02241113
Brand name AVANDIA
Common or Proper name rosiglitazone (as rosiglitazone maleate) tablets
Company Name GLAXOSMITHKLINE INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) ROSIGLITAZONE
Strength(s) 4MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100's
ATC code A10BG
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2020-12-01
Remaining supply date 2021-04-30
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-12-11 French Compare
v5 2020-12-11 English Compare
v4 2020-11-27 French Compare
v3 2020-11-27 English Compare
v2 2020-04-27 French Compare
v1 2020-04-27 English Compare

Showing 1 to 6 of 6